FitLife Brands, Inc. — Form 10-Q Summary
Business context and reporting period
FitLife Brands, Inc. develops, manufactures, and distributes nutritional supplements under the NDS, PMD, SirenLabs, and CoreActive brands, primarily through franchised GNC locations in the United States and internationally. The company marketed more than 50 products through over 1,100 GNC franchise locations. This report covers the three and nine months ended September 30, 2014. The interim consolidated financial statements are unaudited and were prepared using normal recurring adjustments.
Financial performance and position
| Metric | Three months ended September 30, 2014 | Three months ended September 30, 2013 | Nine months ended September 30, 2014 | Nine months ended September 30, 2013 |
|---|---|---|---|---|
| Revenue | $5.492 million | $4.892 million | $17.812 million | $16.008 million |
| Gross profit | $1.846 million | $1.750 million | $6.451 million | $5.885 million |
| Operating income | $640,369 | $482,732 | $2.384 million | $1.601 million |
| Net income | $564,079 | $485,591 | $2.183 million | $1.543 million |
| Basic EPS | $0.07 | $0.06 | $0.27 | $0.20 |
| Diluted EPS | $0.07 | $0.05 | $0.25 | $0.17 |
Calculated margins were approximately 33.6% gross, 11.7% operating, and 10.3% net for the third quarter; nine-month margins were approximately 36.2%, 13.4%, and 12.3%, respectively.
- Cash was $3.618 million at September 30, 2014, compared with $3.305 million at December 31, 2013.
- Accounts receivable increased to $3.056 million from $1.260 million, principally due to the transition to GNC’s centralized distribution platform.
- Inventory declined to $2.511 million from $2.753 million.
- Total assets were $11.070 million, versus $9.230 million at December 31, 2013.
- Total liabilities were $3.858 million, compared with $4.422 million at year-end 2013. Debt included a $437,089 revolving line of credit and a $2.071 million term loan, for total notes payable of $2.508 million.
- Stockholders’ equity increased to $7.213 million from $4.809 million, primarily reflecting accumulated 2014 earnings and equity activity.
- Net working capital was $7.682 million at September 30, 2014, according to management.
- Net cash provided by operating activities was $630,310 for the first nine months, versus $2.584 million in the prior-year period. Operating cash flow was reduced by a $1.796 million increase in accounts receivable.
- Investing activities provided $47,838, while financing activities used $365,059 for term-loan principal repayments.
Material changes versus the prior comparable period
- Third-quarter revenue increased 12.3% and nine-month revenue increased 11.3%, driven by product demand and, during the nine-month period, sales made ahead of GNC’s centralized distribution transition.
- Third-quarter operating income increased approximately 32.7%, and nine-month operating income increased approximately 48.9%.
- Third-quarter net income increased approximately 16.2%, while nine-month net income increased approximately 41.4%.
- General and administrative expense declined 15.9% in the quarter and 7.5% for the nine-month period, primarily due to lower credit-card processing fees following the GNC distribution transition.
- Selling and marketing expense increased 6.3% in the quarter but declined 2.2% for the nine-month period.
- Interest expense increased to $23,290 in the quarter and $72,684 for the nine-month period, compared with $6,419 and $14,459, respectively, in the prior-year periods.
- Cash generation was materially lower year over year because of working-capital movements, particularly the increase in receivables. The prior-year period also benefited from $2.6 million of term-debt proceeds.
- The company acquired the remaining interests in kaniwa protein extraction intellectual property, recorded the asset at an implied value of $220,000, and recognized a $137,500 gain. It also wrote off its remaining $50,000 investment in YogaEarth.
Guidance, outlook, commentary, risks, and unusual items
- Management expected existing cash and operating cash flow to provide liquidity for the next 12 months and stated that no additional working capital had generally been required since the fourth quarter of 2010, excluding the 2013 recapitalization activity.
- The GNC centralized distribution transition began May 1, 2014. Management expected subsequent periods, including the quarter ending December 31, 2014, to show changes in reported revenue and cost of goods sold because certain distribution costs would be reflected as deductions from revenue rather than cost of goods sold.
- Management expects domestic and international store expansion and additional approved products to support future growth, with international expansion anticipated to become a larger growth driver. No quantified revenue or earnings guidance was provided.
- Management identified reliance on key customers, competition, market demand, product performance, supplier relationships, personnel retention, and accounting-rule changes as significant risks. GNC concentration and the distribution-platform transition are particularly relevant to comparability and liquidity.
- On September 26, 2014, Environmental Research Center, Inc. issued a 60-day notice of intent to sue the company and NDS for alleged California Proposition 65 labeling violations. The company disputes the allegations and intends to defend itself; the potential exposure could not reasonably be estimated.
- The company reported no material impairment of long-lived assets, no related-party transactions, no defaults upon senior securities, and no subsequent events.
- The company reported effective disclosure controls and internal control over financial reporting as of September 30, 2014. The filing did not include an external auditor attestation because the company qualified for the applicable small-reporting-company exemption.
Important facts for investors to verify
- Assess the collectability and timing of the substantially higher accounts receivable balance following the GNC distribution transition.
- Reconcile future revenue and gross-margin trends after distributor-level pricing adjustments change the presentation of distribution costs.
- Review debt maturities and borrowing-base requirements, including the revolving line’s May 15, 2015 maturity and collateral provisions.
- Evaluate whether operating cash flow can sustain growth and debt repayments without additional financing.
- Review the status and potential financial exposure of the Proposition 65 notice.
- Examine the valuation and commercial prospects of the kaniwa intellectual property and the basis for the $137,500 gain.
- Consider dilution from 220,000 outstanding options, 152,725 outstanding warrants, and other equity-based compensation or issuances.
- Verify the company’s ability to use approximately $19.060 million of federal net operating-loss carryforwards, including potential Section 382 limitations.